Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

aemetis inc - AMTX

AMTX

Close Chg Chg %
1.43 -0.04 -2.80%

Closed Market

1.39

-0.04 (2.80%)

Volume: 1.03M

Last Updated:

Dec 31, 2025, 4:00 PM EDT

Trade Now

Company Overview: aemetis inc - AMTX

AMTX Key Data

Open

$1.43

 Day Range

1.38 - 1.48

52 Week Range

1.22 - 3.66

 Market Cap

$94.67M

Shares Outstanding

66.20M

 Public Float

61.52M

Beta

2.29

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$1.60

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

845.69K

  

AMTX Performance

1 Week
 
 2.21%
 
1 Month
 
 -19.65%
 
3 Months
 
 -47.55%
 
1 Year
 
 -48.33%
 
5 Years
 
 -44.18%
 

AMTX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

About aemetis inc - AMTX

Aemetis, Inc. is a renewable fuels and biochemical company, which engages in the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products. It operates through the North America and India geographical segments. The North America segment manages Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, California, the Goodland Plant, Kansas and the research and development facility in Minnesota. The India segment refers to the Kakinada plant, administrative offices in Hyderabad, and holding companies in Nevada and Mauritius. Its products include glycerin, ethanol, food and feed, biodiesel, and edible oils. The company was founded by Eric Armstrong McAfee in 2006 and is headquartered in Cupertino, CA.

AMTX At a Glance

Aemetis, Inc.
20400 Stevens Creek Boulevard
Cupertino, California 95014
Phone 1-408-213-0940 Revenue 267.64M
Industry Chemicals: Specialty Net Income -87,537,000.00
Sector Process Industries 2024 Sales Growth 43.34%
Fiscal Year-end 12 / 2025 Employees 223
View SEC Filings

AMTX Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.461
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -18.824
Enterprise Value to Sales 2.214
Total Debt to Enterprise Value 0.793

AMTX Efficiency

Revenue/Employee 1,200,179.372
Income Per Employee -392,542.601
Receivables Turnover 18.975
Total Asset Turnover 1.065

AMTX Liquidity

Current Ratio 0.31
Quick Ratio 0.134
Cash Ratio 0.006

AMTX Profitability

Gross Margin -0.217
Operating Margin -15.101
Pretax Margin -36.754
Net Margin -32.707
Return on Assets -34.826
Return on Equity N/A
Return on Total Capital -42.504
Return on Invested Capital -64.126

AMTX Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 228.15
Total Debt to Total Assets 181.21
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 183.814
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Aemetis Inc - AMTX

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
211.95M 256.51M 186.72M 267.64M
Sales Growth
+28.02% +21.03% -27.21% +43.34%
Cost of Goods Sold (COGS) incl D&A
204.01M 262.05M 184.70M 268.22M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
5.88M 5.88M 7.30M 8.94M
Depreciation
5.83M 5.83M 7.23M 8.90M
Amortization of Intangibles
46.00K 46.00K 72.00K 46.00K
COGS Growth
+32.02% +28.45% -29.52% +45.22%
Gross Income
7.94M (5.54M) 2.02M (580.00K)
Gross Income Growth
-27.99% -169.72% +136.44% -128.76%
Gross Profit Margin
+3.75% -2.16% +1.08% -0.22%
2021 2022 2023 2024 5-year trend
SG&A Expense
23.76M 28.87M 39.42M 39.84M
Research & Development
- 88.00K 180.00K 152.00K
Other SG&A
23.68M 28.69M 39.27M 39.84M
SGA Growth
+39.01% +21.47% +36.56% +1.06%
Other Operating Expense
- - - -
-
Unusual Expense
- - (1.13M) 47.99M
-
EBIT after Unusual Expense
(14.69M) (82.39M) (37.40M) (40.42M)
Non Operating Income/Expense
(809.00K) 14.34M 2.08M 1.37M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
31.77M 38.66M 64.83M 59.32M
Interest Expense Growth
+2.44% +21.66% +67.71% -8.50%
Gross Interest Expense
36.48M 49.76M 70.43M 64.32M
Interest Capitalized
4.70M 11.10M 5.60M 5.00M
Pretax Income
(47.27M) (106.70M) (100.16M) (98.37M)
Pretax Income Growth
-25.61% -125.71% +6.14% +1.78%
Pretax Margin
-22.30% -41.60% -53.64% -36.75%
Income Tax
(128.00K) 1.05M (53.74M) (10.83M)
Income Tax - Current - Domestic
11.00K 13.00K (55.15M) (12.26M)
Income Tax - Current - Foreign
- 230.00K 1.49M 1.47M
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
(139.00K) 810.00K (74.00K) (41.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(47.15M) (107.76M) (46.42M) (87.54M)
Minority Interest Expense
- - - -
-
Net Income
(47.15M) (107.76M) (46.42M) (87.54M)
Net Income Growth
-28.61% -128.56% +56.92% -88.58%
Net Margin Growth
-22.24% -42.01% -24.86% -32.71%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(47.15M) (107.76M) (46.42M) (87.54M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(47.15M) (107.76M) (46.42M) (87.54M)
EPS (Basic)
-1.5366 -3.1157 -1.2196 -1.907
EPS (Basic) Growth
+11.93% -102.77% +60.86% -56.36%
Basic Shares Outstanding
30.68M 34.59M 38.06M 45.90M
EPS (Diluted)
-1.5366 -3.1157 -1.2196 -1.907
EPS (Diluted) Growth
+11.93% -102.77% +60.86% -56.36%
Diluted Shares Outstanding
30.68M 34.59M 38.06M 45.90M
EBITDA
(9.95M) (28.52M) (30.10M) (31.47M)
EBITDA Growth
-1,112.80% -186.80% -5.54% -4.55%
EBITDA Margin
-4.69% -11.12% -16.12% -11.76%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 6.938
Number of Ratings 3 Current Quarters Estimate -0.214
FY Report Date 03 / 2026 Current Year's Estimate -0.625
Last Quarter’s Earnings -0.208 Median PE on CY Estimate N/A
Year Ago Earnings -1.399 Next Fiscal Year Estimate -0.59
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 3 1
Mean Estimate -0.21 -0.15 -0.62 -0.59
High Estimates -0.17 -0.10 -0.25 -0.59
Low Estimate -0.25 -0.20 -0.82 -0.59
Coefficient of Variance -19.23 -32.89 -51.97 N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 2 2
OVERWEIGHT 0 0 0
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Aemetis Inc - AMTX

Date Name Shares Transaction Value
Jun 11, 2025 Timothy Alan Simon Director 45,261 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $1.98 per share 89,616.78
Jun 11, 2025 Timothy Alan Simon Director 40,632 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $1.98 per share 80,451.36
Jun 11, 2025 Timothy Alan Simon Director 50,261 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $1.98 per share 99,516.78
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,105,701 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,113,236 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,149,998 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,219,998 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,249,998 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,312,498 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,339,582 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,344,582 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 456,821 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.86 per share 392,866.06
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 449,286 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.7 per share 314,500.20
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 412,524 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.7 per share 288,766.80
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 342,524 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.67 per share 229,491.08
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 312,524 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.6 per share 187,514.40
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 250,024 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.92 per share 230,022.08
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 222,940 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $1.71 per share 381,227.40
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 217,940 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.7 per share 152,558.00

Aemetis Inc in the News